
Shares of bitcoin development company Strategy (NASDAQ:MSTR) jumped 8.5% in the morning session after Bitcoin climbed back above $71,000 as President Donald Trump pressed Congress to pass the stalled CLARITY Act at a White House crypto event.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Shares of bitcoin development company Strategy (NASDAQ:MSTR) jumped 8.5% in the morning session after Bitcoin climbed back above $71,000 as President Donald Trump pressed Congress to pass the stalled CLARITY Act at a White House crypto event.

For those seeking strong exposure to AI trends paired with dividend-paying traits - Analog Devices (ADI), Hewlett Packard Enterprise (HPE), and NVIDIA (NVDA) - fit the criteria. Importantly, each sports a favorable Zacks Rank.

MicroStrategy stock hit a two-month high as bitcoin neared $69,800, yet its treasury stays $4.69 billion underwater.
Historic momentum is colliding with increasingly stretched technical conditions
One breakthrough could reshape the post-Keytruda earnings story

Deere is known for tractors and harvesters. But data centers and energy infrastructure fuel its construction business.

Michael Reinking, Senior Market Strategist at the NYSE, recaps a week dominated by Treasury Secretary Bessent, whose doubled liquidity support buybacks reignited the debasement trade, sending gold back above 4,500 and triggering a massive crypto short squeeze that propelled Bitcoin up ~15% and Ethereum up 25%. Escalating Iran tensions pushed ICE Brent into the low 90s after a 60-day ceasefire expired, while equity markets drifted lower with the S&P 500 down ~1.5% as retail earnings disappointed broadly and healthcare surged nearly 4% on landmark cancer trial results from Merck and Moderna. Looking ahead, next week's PCE print, Nvidia earnings, and Fed Chair Warsh's first Jackson Hole speech are the marquee events to watch.

ADP's 20% net margin and $5.2B free cash flow contrast sharply with Microsoft's 40% margin and $67B cash generation, revealing starkly different paths to shareholder value.

<p>Moderna's 177% pop on a Phase 3 cancer-vaccine win rippled far beyond one stock.</p>

Don't bet against Vertex Pharmaceuticals in cystic fibrosis.

Parents spend years telling their kids to stand on their own two feet. Then the housing market comes along and makes those two feet look like they need a very expensive pair of shoes. In a post on Reddit, a...

BP, Excelerate Energy, and Occidental Petroleum raised dividends in 2026 amid strong sector gains, offering solid yields and sustainable payout ratios backed by rising cash flow.

A huge win for Rocket Lab may not be quite so big as it seems.
Profit-taking followed a record-setting rally sparked by the first successful Phase 3 trial of an mRNA cancer treatment.
A fifth consecutive oil-price gain strengthens Chevron's upstream economics after record U.S. production.

Meme coin season added $3 billion in a day. Volume and fee data reveal whether Solana, BNB or Robinhood Chain leads.
Alibaba's aggressive AI infrastructure spending drives record cloud acceleration, while e-commerce faces domestic headwinds and quick commerce shows promising path to profitability.

Google's Marvell deal boosts its custom AI-chip role and challenges Broadcom, making Marvell the more attractive AI stock.

This eVTOL maker could generate massive gains for its long-term investors.
Investing.com -- Anthropic PBC plans to match or exceed the size of SpaceX’s record-breaking initial public offering, Bloomberg reported on Thurdsay citing people familiar with the matter. The artificial intelligence company is advancing preparations for its stock market debut.

We were wrong about SCHD, and the margin of error is impossible to ignore. Here is what actually flipped the script and what it means for every portfolio that followed our advice.

Etsy (ETSY) is positioned for durable growth amid better-than-projected strategy execution and as th

The Claude maker confidentially submitted a draft S-1 to the SEC and could file publicly as soon as the end of August

Cloud and AI product revenue accelerated in the June quarter, but a 75% drop in net income extended Alibaba's run of profit misses to a fifth straight quarter.

While the rest of the tech sector bleeds red Thursday, memory stocks are defying gravity, and the catalyst powering the biggest winner has nothing to do with AI chips.

Axon Enterprise is Thursday's IBD Stock Of The Day as the the S&P 500 maker of Tasers, body cameras and software for law enforcement sees its Dedrone drone defense business take off. Dedrone "was still in its infancy just a year ago, and is quickly becoming one of our largest product lines, surpassing $100 million in quarterly revenue," Axon President Joshua Isner told analysts on the Aug. 5 earnings call. Isner announced on the call that Axon had been among the vendors selected among dozens of applicants for a potential $1.5 billion counter-drone program in a further validation of its technology.

DAR's earnings surge, discounted valuation and DGD strength support upside, but rising costs, flat Feed throughput and capacity limits raise execution risks.

DAR's 12.8% weekly rally is backed by stronger core earnings and DGD economics, but capacity limits, costs and weak momentum may test gains.
A fifth consecutive oil-price increase is strengthening Exxon's cash-flow outlook while reviving inflation risk.

Deere & Co. was one of the best-performing stocks in the S&P 500 on Thursday, after the agricultural and industrial equipment maker posted better-than-expected quarterly results.
Can we count your visit with Google Analytics? No ads, no profiles. Details